Topical Cream Carrying Drug-Loaded Nanogels for Melanoma Treatment
In this study, nanogel creams carrying paclitaxel (PTX) and temozolomide (TMZ) were prepared for the topical treatment of melanoma. PTX and TMZ were first loaded in poly-(D,L-lactide-co-glycolide)-block-poly(ethylene glycol)-block-poly-(D,L-lactide-co-glycolide) (PLAG-b-PEG-b-PLGA) thermosensitive n...
Gespeichert in:
Veröffentlicht in: | Pharmaceutical research 2023-10, Vol.40 (10), p.2291-2301 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 2301 |
---|---|
container_issue | 10 |
container_start_page | 2291 |
container_title | Pharmaceutical research |
container_volume | 40 |
creator | Rahman, Sadia Haque, Tasmima N. Sugandhi, Vrashabh V. Saraswat, Aishwarya L. Xin, Xiaoban Cho, Hyunah |
description | In this study, nanogel creams carrying paclitaxel (PTX) and temozolomide (TMZ) were prepared for the topical treatment of melanoma. PTX and TMZ were first loaded in poly-(D,L-lactide-co-glycolide)-block-poly(ethylene glycol)-block-poly-(D,L-lactide-co-glycolide) (PLAG-b-PEG-b-PLGA) thermosensitive nanogels, which made a transition from a free-flowing sol (formation of micellar network) at 25°C with the z-average particle size of c.a. 96 nm to a gel (aggregation of micelles) at 33°C with the z-average particle size of c.a. 427 nm. An anhydrous absorption ointment base, aquaphor, was then added to drug-loaded nanogels to form nanogel creams carrying PTX and TMZ. Nanogel creams permitted controlled release of the payloads and improved the penetration of the payloads through the rodent skin compared to drug(s)-loaded nanogels. PTX and TMZ in a combination were synergistically effective in inhibiting SK-MEL28, A375, and B16-F10 melanoma cancer cells
in vitro
. Topically applied nanogel creams carrying TMZ/PTX (4 mg/1.5 mg/dose) showed a trend of tumor volume inhibition on B16-F10-bearing xenograft mice
in vivo
. |
doi_str_mv | 10.1007/s11095-023-03506-z |
format | Article |
fullrecord | <record><control><sourceid>gale_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_2795358387</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A773646598</galeid><sourcerecordid>A773646598</sourcerecordid><originalsourceid>FETCH-LOGICAL-c442t-6a864f3b8e8ae56111f35cc3c9a4fbe39b7b9403f1208d6f5436e5638450d9e53</originalsourceid><addsrcrecordid>eNp9kUFv1DAQhS0EotvCH-CAInHh4mJ77Ng-li0UpAUui8TNcpJxlCqJFzs5tL8ely1UIIR8GNnzvadnPUJecHbOGdNvMufMKsoEUAaK1fT2EdlwpYFaJr89JhumhaRGS35CTnO-ZowZbuVTcgKacaEANuTtPh6G1o_VNqGfqq1P6WaY--oyrT3dRd9hV332c-xxzFWIqfqEY7lOvtoXwTLhvDwjT4IfMz6_n2fk6_t3--0Huvty9XF7saOtlGKhtTe1DNAYNB5VzTkPoNoWWutlaBBsoxsrGQQumOnqoCTUhQMjFessKjgjr4--hxS_r5gXNw25xbHkwbhmJ7RVoAwYXdBXf6HXcU1zSeeEsdwCE5Y_UL0f0Q1ziEvy7Z2pu9Aaalkrawp1_g-qnA6noY0zhqG8_yEQR0GbYs4JgzukYfLpxnHm7opzx-JcKc79LM7dFtHL-8RrM2H3W_KrqQLAEchlNfeYHr70H9sfXi2gSQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2891930291</pqid></control><display><type>article</type><title>Topical Cream Carrying Drug-Loaded Nanogels for Melanoma Treatment</title><source>MEDLINE</source><source>SpringerLink Journals</source><creator>Rahman, Sadia ; Haque, Tasmima N. ; Sugandhi, Vrashabh V. ; Saraswat, Aishwarya L. ; Xin, Xiaoban ; Cho, Hyunah</creator><creatorcontrib>Rahman, Sadia ; Haque, Tasmima N. ; Sugandhi, Vrashabh V. ; Saraswat, Aishwarya L. ; Xin, Xiaoban ; Cho, Hyunah</creatorcontrib><description>In this study, nanogel creams carrying paclitaxel (PTX) and temozolomide (TMZ) were prepared for the topical treatment of melanoma. PTX and TMZ were first loaded in poly-(D,L-lactide-co-glycolide)-block-poly(ethylene glycol)-block-poly-(D,L-lactide-co-glycolide) (PLAG-b-PEG-b-PLGA) thermosensitive nanogels, which made a transition from a free-flowing sol (formation of micellar network) at 25°C with the z-average particle size of c.a. 96 nm to a gel (aggregation of micelles) at 33°C with the z-average particle size of c.a. 427 nm. An anhydrous absorption ointment base, aquaphor, was then added to drug-loaded nanogels to form nanogel creams carrying PTX and TMZ. Nanogel creams permitted controlled release of the payloads and improved the penetration of the payloads through the rodent skin compared to drug(s)-loaded nanogels. PTX and TMZ in a combination were synergistically effective in inhibiting SK-MEL28, A375, and B16-F10 melanoma cancer cells
in vitro
. Topically applied nanogel creams carrying TMZ/PTX (4 mg/1.5 mg/dose) showed a trend of tumor volume inhibition on B16-F10-bearing xenograft mice
in vivo
.</description><identifier>ISSN: 0724-8741</identifier><identifier>EISSN: 1573-904X</identifier><identifier>DOI: 10.1007/s11095-023-03506-z</identifier><identifier>PMID: 37012533</identifier><language>eng</language><publisher>New York: Springer US</publisher><subject>Animals ; Biochemistry ; Biomedical and Life Sciences ; Biomedical Engineering and Bioengineering ; Biomedicine ; Cell Line, Tumor ; Controlled release ; Dermatologic agents ; Dermatology ; Drug Carriers ; Drug therapy ; Formulae, receipts, prescriptions ; Humans ; Medical Law ; Melanoma ; Melanoma - drug therapy ; Mice ; Micelles ; Nanogels ; Original Research Article ; Paclitaxel ; Particle size ; Pharmacology/Toxicology ; Pharmacy ; Polyethylene glycol ; Polyethylene Glycols ; Polylactide-co-glycolide ; Skin ; Temozolomide</subject><ispartof>Pharmaceutical research, 2023-10, Vol.40 (10), p.2291-2301</ispartof><rights>The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2023. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.</rights><rights>2023. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.</rights><rights>COPYRIGHT 2023 Springer</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c442t-6a864f3b8e8ae56111f35cc3c9a4fbe39b7b9403f1208d6f5436e5638450d9e53</citedby><cites>FETCH-LOGICAL-c442t-6a864f3b8e8ae56111f35cc3c9a4fbe39b7b9403f1208d6f5436e5638450d9e53</cites><orcidid>0000-0001-7150-4191</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s11095-023-03506-z$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s11095-023-03506-z$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,776,780,27901,27902,41464,42533,51294</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/37012533$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Rahman, Sadia</creatorcontrib><creatorcontrib>Haque, Tasmima N.</creatorcontrib><creatorcontrib>Sugandhi, Vrashabh V.</creatorcontrib><creatorcontrib>Saraswat, Aishwarya L.</creatorcontrib><creatorcontrib>Xin, Xiaoban</creatorcontrib><creatorcontrib>Cho, Hyunah</creatorcontrib><title>Topical Cream Carrying Drug-Loaded Nanogels for Melanoma Treatment</title><title>Pharmaceutical research</title><addtitle>Pharm Res</addtitle><addtitle>Pharm Res</addtitle><description>In this study, nanogel creams carrying paclitaxel (PTX) and temozolomide (TMZ) were prepared for the topical treatment of melanoma. PTX and TMZ were first loaded in poly-(D,L-lactide-co-glycolide)-block-poly(ethylene glycol)-block-poly-(D,L-lactide-co-glycolide) (PLAG-b-PEG-b-PLGA) thermosensitive nanogels, which made a transition from a free-flowing sol (formation of micellar network) at 25°C with the z-average particle size of c.a. 96 nm to a gel (aggregation of micelles) at 33°C with the z-average particle size of c.a. 427 nm. An anhydrous absorption ointment base, aquaphor, was then added to drug-loaded nanogels to form nanogel creams carrying PTX and TMZ. Nanogel creams permitted controlled release of the payloads and improved the penetration of the payloads through the rodent skin compared to drug(s)-loaded nanogels. PTX and TMZ in a combination were synergistically effective in inhibiting SK-MEL28, A375, and B16-F10 melanoma cancer cells
in vitro
. Topically applied nanogel creams carrying TMZ/PTX (4 mg/1.5 mg/dose) showed a trend of tumor volume inhibition on B16-F10-bearing xenograft mice
in vivo
.</description><subject>Animals</subject><subject>Biochemistry</subject><subject>Biomedical and Life Sciences</subject><subject>Biomedical Engineering and Bioengineering</subject><subject>Biomedicine</subject><subject>Cell Line, Tumor</subject><subject>Controlled release</subject><subject>Dermatologic agents</subject><subject>Dermatology</subject><subject>Drug Carriers</subject><subject>Drug therapy</subject><subject>Formulae, receipts, prescriptions</subject><subject>Humans</subject><subject>Medical Law</subject><subject>Melanoma</subject><subject>Melanoma - drug therapy</subject><subject>Mice</subject><subject>Micelles</subject><subject>Nanogels</subject><subject>Original Research Article</subject><subject>Paclitaxel</subject><subject>Particle size</subject><subject>Pharmacology/Toxicology</subject><subject>Pharmacy</subject><subject>Polyethylene glycol</subject><subject>Polyethylene Glycols</subject><subject>Polylactide-co-glycolide</subject><subject>Skin</subject><subject>Temozolomide</subject><issn>0724-8741</issn><issn>1573-904X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNp9kUFv1DAQhS0EotvCH-CAInHh4mJ77Ng-li0UpAUui8TNcpJxlCqJFzs5tL8ely1UIIR8GNnzvadnPUJecHbOGdNvMufMKsoEUAaK1fT2EdlwpYFaJr89JhumhaRGS35CTnO-ZowZbuVTcgKacaEANuTtPh6G1o_VNqGfqq1P6WaY--oyrT3dRd9hV332c-xxzFWIqfqEY7lOvtoXwTLhvDwjT4IfMz6_n2fk6_t3--0Huvty9XF7saOtlGKhtTe1DNAYNB5VzTkPoNoWWutlaBBsoxsrGQQumOnqoCTUhQMjFessKjgjr4--hxS_r5gXNw25xbHkwbhmJ7RVoAwYXdBXf6HXcU1zSeeEsdwCE5Y_UL0f0Q1ziEvy7Z2pu9Aaalkrawp1_g-qnA6noY0zhqG8_yEQR0GbYs4JgzukYfLpxnHm7opzx-JcKc79LM7dFtHL-8RrM2H3W_KrqQLAEchlNfeYHr70H9sfXi2gSQ</recordid><startdate>20231001</startdate><enddate>20231001</enddate><creator>Rahman, Sadia</creator><creator>Haque, Tasmima N.</creator><creator>Sugandhi, Vrashabh V.</creator><creator>Saraswat, Aishwarya L.</creator><creator>Xin, Xiaoban</creator><creator>Cho, Hyunah</creator><general>Springer US</general><general>Springer</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7TK</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0001-7150-4191</orcidid></search><sort><creationdate>20231001</creationdate><title>Topical Cream Carrying Drug-Loaded Nanogels for Melanoma Treatment</title><author>Rahman, Sadia ; Haque, Tasmima N. ; Sugandhi, Vrashabh V. ; Saraswat, Aishwarya L. ; Xin, Xiaoban ; Cho, Hyunah</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c442t-6a864f3b8e8ae56111f35cc3c9a4fbe39b7b9403f1208d6f5436e5638450d9e53</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Animals</topic><topic>Biochemistry</topic><topic>Biomedical and Life Sciences</topic><topic>Biomedical Engineering and Bioengineering</topic><topic>Biomedicine</topic><topic>Cell Line, Tumor</topic><topic>Controlled release</topic><topic>Dermatologic agents</topic><topic>Dermatology</topic><topic>Drug Carriers</topic><topic>Drug therapy</topic><topic>Formulae, receipts, prescriptions</topic><topic>Humans</topic><topic>Medical Law</topic><topic>Melanoma</topic><topic>Melanoma - drug therapy</topic><topic>Mice</topic><topic>Micelles</topic><topic>Nanogels</topic><topic>Original Research Article</topic><topic>Paclitaxel</topic><topic>Particle size</topic><topic>Pharmacology/Toxicology</topic><topic>Pharmacy</topic><topic>Polyethylene glycol</topic><topic>Polyethylene Glycols</topic><topic>Polylactide-co-glycolide</topic><topic>Skin</topic><topic>Temozolomide</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Rahman, Sadia</creatorcontrib><creatorcontrib>Haque, Tasmima N.</creatorcontrib><creatorcontrib>Sugandhi, Vrashabh V.</creatorcontrib><creatorcontrib>Saraswat, Aishwarya L.</creatorcontrib><creatorcontrib>Xin, Xiaoban</creatorcontrib><creatorcontrib>Cho, Hyunah</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing & Allied Health Database</collection><collection>Neurosciences Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>MEDLINE - Academic</collection><jtitle>Pharmaceutical research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Rahman, Sadia</au><au>Haque, Tasmima N.</au><au>Sugandhi, Vrashabh V.</au><au>Saraswat, Aishwarya L.</au><au>Xin, Xiaoban</au><au>Cho, Hyunah</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Topical Cream Carrying Drug-Loaded Nanogels for Melanoma Treatment</atitle><jtitle>Pharmaceutical research</jtitle><stitle>Pharm Res</stitle><addtitle>Pharm Res</addtitle><date>2023-10-01</date><risdate>2023</risdate><volume>40</volume><issue>10</issue><spage>2291</spage><epage>2301</epage><pages>2291-2301</pages><issn>0724-8741</issn><eissn>1573-904X</eissn><abstract>In this study, nanogel creams carrying paclitaxel (PTX) and temozolomide (TMZ) were prepared for the topical treatment of melanoma. PTX and TMZ were first loaded in poly-(D,L-lactide-co-glycolide)-block-poly(ethylene glycol)-block-poly-(D,L-lactide-co-glycolide) (PLAG-b-PEG-b-PLGA) thermosensitive nanogels, which made a transition from a free-flowing sol (formation of micellar network) at 25°C with the z-average particle size of c.a. 96 nm to a gel (aggregation of micelles) at 33°C with the z-average particle size of c.a. 427 nm. An anhydrous absorption ointment base, aquaphor, was then added to drug-loaded nanogels to form nanogel creams carrying PTX and TMZ. Nanogel creams permitted controlled release of the payloads and improved the penetration of the payloads through the rodent skin compared to drug(s)-loaded nanogels. PTX and TMZ in a combination were synergistically effective in inhibiting SK-MEL28, A375, and B16-F10 melanoma cancer cells
in vitro
. Topically applied nanogel creams carrying TMZ/PTX (4 mg/1.5 mg/dose) showed a trend of tumor volume inhibition on B16-F10-bearing xenograft mice
in vivo
.</abstract><cop>New York</cop><pub>Springer US</pub><pmid>37012533</pmid><doi>10.1007/s11095-023-03506-z</doi><tpages>11</tpages><orcidid>https://orcid.org/0000-0001-7150-4191</orcidid></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0724-8741 |
ispartof | Pharmaceutical research, 2023-10, Vol.40 (10), p.2291-2301 |
issn | 0724-8741 1573-904X |
language | eng |
recordid | cdi_proquest_miscellaneous_2795358387 |
source | MEDLINE; SpringerLink Journals |
subjects | Animals Biochemistry Biomedical and Life Sciences Biomedical Engineering and Bioengineering Biomedicine Cell Line, Tumor Controlled release Dermatologic agents Dermatology Drug Carriers Drug therapy Formulae, receipts, prescriptions Humans Medical Law Melanoma Melanoma - drug therapy Mice Micelles Nanogels Original Research Article Paclitaxel Particle size Pharmacology/Toxicology Pharmacy Polyethylene glycol Polyethylene Glycols Polylactide-co-glycolide Skin Temozolomide |
title | Topical Cream Carrying Drug-Loaded Nanogels for Melanoma Treatment |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-04T12%3A38%3A17IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Topical%20Cream%20Carrying%20Drug-Loaded%20Nanogels%20for%20Melanoma%20Treatment&rft.jtitle=Pharmaceutical%20research&rft.au=Rahman,%20Sadia&rft.date=2023-10-01&rft.volume=40&rft.issue=10&rft.spage=2291&rft.epage=2301&rft.pages=2291-2301&rft.issn=0724-8741&rft.eissn=1573-904X&rft_id=info:doi/10.1007/s11095-023-03506-z&rft_dat=%3Cgale_proqu%3EA773646598%3C/gale_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2891930291&rft_id=info:pmid/37012533&rft_galeid=A773646598&rfr_iscdi=true |